Panacea Biotec Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec has informed the exchanges that its trading window will remain closed for all designated persons and their immediate relatives starting April 1, 2026. The window will reopen only 48 hours after the company announces its audited financial results for the quarter and full financial year ending March 31, 2026. The Board meeting date to approve these results has not yet been disclosed and will be communicated later. This is a routine compliance measure required under SEBI's Insider Trading Regulations.
This is a standard regulatory filing and not a material event. It restricts insiders from trading in the company's stock ahead of the upcoming results, but has no direct impact on the stock price or shareholders. Investors should watch for the upcoming Q4/FY26 results announcement for any meaningful business updates.